Also listed on Genewave, an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).
Term ends Oct 31, 2035 · High confidence
20-year base term ends Nov 27, 2034
Held by Gen-Probe Incorporated
Filed May 27, 2016 as application 15/039,860 · Granted May 19, 2020
Base term plus 338 days of patent term adjustment (USPTO delay)
Today
2014
2035
Clock starts
Nov 27, 2014
Nov 27, 2014
Term ends
Oct 31, 2035
Oct 31, 2035
Granted
May 19, 2020
May 19, 2020
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
338
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 338 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 27, 2014, when application PCT/EP2014/075868, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2016) | Nov 27, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +338 days, USPTO patent term adjustment record | Oct 31, 2035 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 31, 2035 | High confidence |
This family
| US 10,654,039 | this patent Oct 2035 | Oct 2035 |
| US 11,813,609 | In force Oct 2035 | Oct 2035 |
| US 12,275,009 | In force no later than Nov 2034 | no later than Nov 2034 |
| Application 18/763,917 | Pending not computed | not computed |
| Application 19/027,187 | Pending not computed | not computed |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 30, 2016 Reel 40462, frame 560 | Marcy, Yann; Artigue, Marc; Le Masne, Quentin; Marq, Kevin | Genewave | Assignment of Assignor's Interest |
| Aug 26, 2024 Reel 68400, frame 684 | Mobidiag Oy | Gen-Probe Incorporated | Assignment of Assignor's Interest |
| Aug 26, 2024 Reel 68788, frame 810 | Genewave SAS | Mobidiag Oy | Assignment of Assignor's Interest |
| Mar 30, 2026 Reel 74227, frame 557 | Mobidiag Oy | Gen-Probe Incorporated | Assignment of Assignor's Interest |
| Mar 30, 2026 Reel 75325, frame 802 | Genewave | Mobidiag Oy | Assignment of Assignor's Interest |
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2035
Term ends Oct 31, 2035. Maintenance fees still fall due before then
Note
The 338 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
14
later US patents cite this one
That is top 25% of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.